Prolonged hematological remission by mitoxantrone and interferon - α-2b in a child with resistant Philadelphia chromosome-positive chronic myelogenous leukemia-Reference-Cited by-同舟云学术

Prolonged hematological remission by mitoxantrone and interferon - α-2b in a child with resistant Philadelphia chromosome-positive chronic myelogenous leukemia

Published:2009-04-24 Issue:3 Volume:51 Page:173-174
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Duru Feride,Tuncer Murat,Hiçsönmez Gönül

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.1993.tb00620.x/fullpdf

Reference7 articles.

1. Hematologic remission and cytogenetic improvement induced by recombinant human interferon alphaA in chronic myelogenous leukemia;Talpaz;N Engl J Med,1986

2. Interferon alpha 2b as therapy for Ph-positive chronic myelogenous leukemia: A study of 82 patients treated with intermittent or daily administration;Alimena;Blood,1988

3. DNA-flow cytometry studies in a blood and marrow cells from chronic myelogenous leukemia patients, treated with interferon alpha-2b;Wandl;Leukemia Res,1990

4. Combined recombinant human interferon alpha2 and cytotoxic agents studied in a clonogenic assay;Welander;Int J Cancer,1985

5. Inital cytoreduction by mitoxantrone and cytarabine has no impact on the outcome of interferon alpha-2b therapy in chronic myelogenous leukemia;Nielsen;Eur J Haematol,1992

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Hematological Remission After a Single Dose of Mitoxantrone in a Child with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia;Pediatric Hematology and Oncology;1997-01